Massively Parallel Sequencing
- Use to detect variants in genes known to cause laterality defects such as situs inversus, heterotaxy, or complex congenital heart defects.
- Regions of low coverage and reported variants are confirmed by Sanger sequencing as necessary.
Laterality defects, such as heterotaxy and situs inversus, are developmental defects characterized by the abnormal placement of the abdominal (visceral) organs. Situs inversus totalis involves the complete transposition of all visceral organs, while heterotaxy (situs ambiguus) is used to describe any deviation from the standard placement of organs in the abdomen. Laterality defects can also impact the left-right symmetry in the heart, and many individuals with heterotaxy have congenital heart defects. These conditions are clinically and genetically heterogeneous and have been associated with pathogenic variants in a number of different genes that are involved in both early embryo development and pathways related to left-right patterning. Clinical symptoms are variable and depend on the function of the organs involved.
Disease Overview
Symptoms/Associated Disorders
Symptoms vary depending on the organs involved and may include cyanosis or other complications of congenital heart disease, digestive problems due to intestinal malrotation, or immunologic disorders due to abnormal spleen function.
Primary ciliary dyskinesia (Kartagener syndrome) is an associated disorder caused by abnormalities of the motile cilia, which leads to sinopulmonary disease, infertility, and, in 50% of cases, situs inversus. For more information, see the Primary Ciliary Dyskinesia Panel Test Fact Sheet.
Epidemiology/Prevalence
Heterotaxy syndrome affects approximately one in 10,000 individuals and is causative of about 3% of cases of congenital heart defects.
Genetics
Etiology
Pathogenic germline variants in genes associated with left-right symmetry in early embryo development
Penetrance
Varies; some associated genes exhibit reduced penetrance
Inheritance
Varies; see Genes Tested table
Test Interpretation
Clinical Sensitivity
Variable, dependent on phenotype/condition
Analytical Sensitivity
For massively parallel sequencing:
Variant Class | Analytical Sensitivity (PPA) Estimatea (%) | Analytical Sensitivity (PPA) 95% Credibility Regiona (%) |
---|---|---|
SNVs |
99.2 |
96.9-99.4 |
Deletions 1-10 bp |
93.8 |
84.3-98.2 |
Deletions 11-44 bp |
99.9 |
87.8-100 |
Insertions 1-10 bp |
94.8 |
86.8-98.5 |
Insertions 11-23 bp |
99.9 |
62.1-100 |
aGenes included on this test are a subset of a larger methods-based validation from which the PPA values are derived. bp, base pairs; PPA, positive percent agreement; SNVs, single nucleotide variants |
Limitations
- A negative result does not exclude a heritable laterality defect.
- Diagnostic errors can occur due to rare sequence variations.
- Interpretation of this test result may be impacted if this patient has had an allogeneic stem cell transplantation.
- The following will not be evaluated:
- Variants outside the coding regions and intron-exon boundaries of targeted gene(s)
- Regulatory region and deep intronic variants
- Large deletions/duplications in any of the tested genes
- Noncoding transcripts
- The following exons are not sequenced due to technical limitations of the assay:
- ANKS6(NM_173551) exon(s) 1
- ARMC4(NM_001290020) exon(s) 9
- ARMC4(NM_001290021) exon(s) 13
- ARMC4(NM_001312689) exon(s) 4
- ARMC4(NM_018076) exon(s) 9
- CCDC103(NM_001258397) exon(s) 4
- CCDC114(NM_001364171) exon(s) 3
- CCDC114(NM_001364171) partial exon(s) 4(Chr19:48822049-48822069)
- CCDC40(NM_001243342) exon(s) 18
- CFAP298(NM_001350335) partial exon(s) 5(Chr21:33975399-33975450)
- CFAP298(NM_001350337) partial exon(s) 6(Chr21:33974534-33974561)
- DNAAF5(NM_017802) exon(s) 1
- DNAI2(NM_001353167) exon(s) 13
- GATA6(NM_005257) partial exon(s) 2(Chr18:19751812-19751963)
- PKD1L1(NM_138295) partial exon(s) 8(Chr7:47955029-47955060)
- SPAG1(NM_001374321) partial exon(s) 11(Chr8:101225456-101225529)
- SPAG1(NM_003114) partial exon(s) 11(Chr8:101225456-101225529)
- SPAG1(NM_172218) partial exon(s) 11(Chr8:101225456-101225529)
- The following may not be detected:
- Deletions/duplications/insertions of any size by massively parallel sequencing
- Some variants due to technical limitations in the presence of pseudogenes, repetitive, or homologous regions
- Low-level somatic variants
Genes Tested
Gene Name | MIM # | Associated Disorder | Inheritance Pattern |
---|---|---|---|
ANKS6 |
615370 |
Nephronophthisis |
AR |
ARL2BP |
615407 |
Retinitis pigmentosa with or without situs inversus |
AR |
ARMC4 |
615408 |
PCD |
AR |
CCDC103 |
614677 |
PCD |
AR |
CCDC114 |
615038 |
PCD |
AR |
CCDC151 |
615956 |
PCD |
AR |
CCDC39 |
613798 |
PCD |
AR |
CCDC40 |
613799 |
PCD |
AR |
CFAP298 |
615494 |
PCD |
AR |
CFAP53 |
614759 |
Visceral heterotaxy |
AR |
CRELD1 |
607170 |
Atrioventricular septal defect, partial, with heterotaxy syndrome |
AD |
DNAAF1 |
613190 |
PCD |
AR |
DNAAF2 |
612517 |
PCD |
AR |
DNAAF3 |
614566 |
PCD |
AR |
DNAAF4 |
608706 |
PCD |
AR |
DNAAF5 |
614864 |
PCD |
AR |
DNAH1 |
603332 |
PCD |
AR |
DNAH11 |
603339 |
PCD |
AR |
DNAH5 |
603335 |
PCD |
AR |
DNAI1 |
604366 |
PCD |
AR |
DNAI2 |
605483 |
PCD |
AR |
DNAL1 |
610062 |
PCD |
AR |
FOXH1 |
603621 |
Congenital heart defects (multiple types) |
AD |
GATA4 |
600576 |
Congenital heart defects (multiple types) |
AD |
GATA6 |
601656 |
Congenital heart defects (multiple types) |
AD |
INVS |
243305 |
Nephronophthisis |
AR |
LRRC6 |
614930 |
PCD |
AR |
MMP21 |
608416 |
Visceral heterotaxy |
AR |
NKX2-5 |
600584 |
Congenital heart defects (multiple types) |
AD |
NME8 |
607421 |
PCD |
AR |
NODAL |
601265 |
Visceral heterotaxy |
AD |
PIH1D3 |
300933 |
PCD |
XLR |
PKD1L1 |
609721 |
Visceral heterotaxy |
AR |
SPAG1 |
603395 |
PCD |
AR |
ZIC3 |
300265 |
Visceral heterotaxy, Congenital heart defects |
XLR |
ZMYND10 |
607070 |
PCD |
AR |
AD, autosomal dominant; AR, autosomal recessive; PCD, primary ciliary dyskinesia; XLR, X-linked recessive |
26467876
Teele SA, Jacobs JP, Border WL, et al. Heterotaxy syndrome: proceedings from the 10th International PCICS meeting. World J Pediatr Congenit Heart Surg. 2015;6(4):616-629.